Detection of Vascular Endothelial Growth Factor-A in Patients with Gastric Cancer and its Clinical Significance

丁士刚,林三仁,董秀云,曲恒怡,杨雪玲,黄淑美,刘文静,周丽雅

DOI: https://doi.org/10.3969/j.issn.1008-7125.2004.01.008

2004-01-01

Abstract:Background: The growth and metastasis of gastric cancer is closely related with angiogenesis. Vascular endothelial growth factor (VEGF)-A, which is abundantly expressed in tumor tissues, is essential for tumor angiogenesis. Aims: To estimate the level of circulating VEGF-A in patients with gastric cancer and to investigate its clinical significance. Methods: Enzyme-linked immunosorbent assay (ELISA) was used to detect the plasma and serum levels of VEGF-A in 135 patients with gastric cancer and 48 benign gastric diseases identified by endoscopy and histology. The serum level of VEGF-A was assayed in 10 patients with gastric cancer before operation, 10 benign gastric diseases one week later, and 16 patients with gastric cancer three weeks after operation. Results: The plasma and serum levels of VEGF-A were significantly higher in 135 patients with gastric cancer than those in 48 benign gastric diseases (plasma level: 74.1 pg/ml±96.0 pg/ml vs. 23.7 pg/ml ±16.9 pg/ml, P<0.001; serum level: 342.1 pg/ml± 277.8 pg/ml vs. 80.0 pg/ml±36.4 pg/ml, P<0.000 1). The serum levels of VEGF-A at the two time points one week apart were similar in 10 patients with gastric cancer before operation and 10 benign gastric diseases (264.3 pg/ml±148.2 pg/ml vs. 265.2 pg/ml±142.9 pg/ml, P>0.05; 71.4 pg/ml±16.2 pg/ml vs. 78.0 pg/ml ± 14.3 pg/ml, P>0.05). However, there was significant difference between the serum level of VEGF-A in 16 patients with gastric cancer prior and three weeks after operation (328.4 pg/ml±141.7 pg/ml vs. 103.5 pg/ml±52.2 pg/ml, P<0.000 1). Conclusions: The plasma and serum levels of VEGF-A are significantly increased in patients with gastric cancer, and the serum level of VEGF-A is more stable. After surgical removal of gastric cancer, the serum level of VEGF-A is significantly reduced.